QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=F5D08C3B7790B832EBA45D4F19A08434;jsessionid=B6A0F865AAFFBDCFC6E050C65121AFB7;jsessionid=DBB7B6984B77817560115579DA689B50;jsessionid=9A2EC3B53A3ED6A5C095DC6C53D2D6F5;jsessionid=74063D90FA3EC87245EA506CE02113BE (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=F5D08C3B7790B832EBA45D4F19A08434;jsessionid=B6A0F865AAFFBDCFC6E050C65121AFB7;jsessionid=DBB7B6984B77817560115579DA689B50;jsessionid=9A2EC3B53A3ED6A5C095DC6C53D2D6F5;jsessionid=74063D90FA3EC87245EA506CE02113BE